Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreFrom 2016, the Innovation Fund has served as an instrument of central health policy to promote new f...
Read moreThis law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...
Read moreWe analyse subscription-based agreements for antibiotics in Europe to understand how it may address ...
Read moreThe legislation is an updated, smaller version of The Build Back Better Act (BBBA) which the US Sena...
Read moreOne notable change from the last released updated bill was the removal of the solidarity levy of 2 b...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe Innovative Medicines Fund launched on 7th June 2022 The Innovative Medicines Fund (IMF), which w...
Read moreThrough the new fund, £340 million is to be made available to purchase promising, potentially life-...
Read more